Experience

Davis Polk is advising JP Morgan as lead financial adviser to Symantec Corporation in connection with its $4.65 billion acquisition of Blue Coat, Inc. The closing of the transaction, which…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX Company of $350 million aggregate principal amount of its 4.200%…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Under Armour, Inc. of $600 million aggregate principal amount of its 3…

Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by CVR Partners, LP and CVR Nitrogen Finance Corporation of $645 million aggregate…

Davis Polk advised Baker Hughes Incorporated in connection with its waterfall cash tender offer for $1 billion aggregate principal amount of six series of outstanding notes. Baker Hughes…

Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million aggregate principal amount of 2.75% convertible senior notes due…

Davis Polk advised Aetna Inc. on its SEC-registered notes offering of $13 billion aggregate principal amount of senior notes in eight series, consisting of $500 million aggregate principal…

Davis Polk advised DONG Energy A/S on the initial public offering of shares and listing on the Nasdaq Copenhagen A/S under the symbol “DENERG.” The offering comprised a sale of 72,834,393…

Davis Polk advised the representatives of the initial purchasers on Rule 144A/Regulation S offerings by Mylan N.V. (“Mylan”) of $1.0 billion aggregate principal amount of its 2.500% senior…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Pernod Ricard of $600 million aggregate principal amount of 3.250% fixed-rate notes due…